Jacqueline Fátima Martins de Almeida, Cristina Romei, Teresa Ramone, Roberta Casalini, Raffaele Ciampi, Beatrice Fuochi, Francesca Signorini, Clara Ugolini, Virginia Cappagli, Laura Sterian Ward, Rossella Elisei
{"title":"多灶散发性甲状腺髓样癌和C细胞增生的遗传起源。","authors":"Jacqueline Fátima Martins de Almeida, Cristina Romei, Teresa Ramone, Roberta Casalini, Raffaele Ciampi, Beatrice Fuochi, Francesca Signorini, Clara Ugolini, Virginia Cappagli, Laura Sterian Ward, Rossella Elisei","doi":"10.1093/ejendo/lvaf109","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Sporadic medullary thyroid cancer (sMTC) mostly presents as a single lesion, but additional tumor foci may be present. The present study aimed to analyze the mutation profile of different tumor foci of multifocal sMTC to verify whether they represent an intra-organ metastatic dissemination or if they are independent tumors. Moreover, the genetics of C-cell hyperplasia (CCH) associated with sMTC was studied to verify whether CCH could be considered preneoplastic or reactive lesions.</p><p><strong>Methods: </strong>Thirty-eight multifocal sMTCs and 15 sMTCs with associated CCH were included: A total of 106 tumor foci and 25 different CCH areas were studied. The mutational status was analyzed by Next-Generation Sequencing and/or droplet-digital PCR.</p><p><strong>Results: </strong>Thirty-one/38 (81.6%) sMTCs had a somatic mutation in the main tumor, while 7/38 (18.4%) cases were negative. Thirty/31 (96.8%) mutated sMTCs had a single mutation, while 3 different mutations were detected in 1 case (3.2%). Twenty-eight/31 (90%) mutated sMTCs showed the same mutation profile in the main tumors and in all secondary foci, while 3 cases were discordant. Eleven/15 (73.4%) sMTC with CCH showed a somatic mutation in the main tumor, while 4 (26.6%) were negative. Only 1/11 (9%) mutated cases showed the same mutation in the main tumor and in the CCH.</p><p><strong>Conclusions: </strong>Our data demonstrate that multiple foci of sMTC share the same driver mutation as the main tumor and support the hypothesis that they are intrathyroidal metastases. Most of the CCH associated with sMTC should not be considered a preneoplastic lesion as they are negative for the mutation of the main sMTC.</p>","PeriodicalId":11884,"journal":{"name":"European Journal of Endocrinology","volume":" ","pages":"737-743"},"PeriodicalIF":5.2000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Genetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia.\",\"authors\":\"Jacqueline Fátima Martins de Almeida, Cristina Romei, Teresa Ramone, Roberta Casalini, Raffaele Ciampi, Beatrice Fuochi, Francesca Signorini, Clara Ugolini, Virginia Cappagli, Laura Sterian Ward, Rossella Elisei\",\"doi\":\"10.1093/ejendo/lvaf109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Sporadic medullary thyroid cancer (sMTC) mostly presents as a single lesion, but additional tumor foci may be present. The present study aimed to analyze the mutation profile of different tumor foci of multifocal sMTC to verify whether they represent an intra-organ metastatic dissemination or if they are independent tumors. Moreover, the genetics of C-cell hyperplasia (CCH) associated with sMTC was studied to verify whether CCH could be considered preneoplastic or reactive lesions.</p><p><strong>Methods: </strong>Thirty-eight multifocal sMTCs and 15 sMTCs with associated CCH were included: A total of 106 tumor foci and 25 different CCH areas were studied. The mutational status was analyzed by Next-Generation Sequencing and/or droplet-digital PCR.</p><p><strong>Results: </strong>Thirty-one/38 (81.6%) sMTCs had a somatic mutation in the main tumor, while 7/38 (18.4%) cases were negative. Thirty/31 (96.8%) mutated sMTCs had a single mutation, while 3 different mutations were detected in 1 case (3.2%). Twenty-eight/31 (90%) mutated sMTCs showed the same mutation profile in the main tumors and in all secondary foci, while 3 cases were discordant. Eleven/15 (73.4%) sMTC with CCH showed a somatic mutation in the main tumor, while 4 (26.6%) were negative. Only 1/11 (9%) mutated cases showed the same mutation in the main tumor and in the CCH.</p><p><strong>Conclusions: </strong>Our data demonstrate that multiple foci of sMTC share the same driver mutation as the main tumor and support the hypothesis that they are intrathyroidal metastases. Most of the CCH associated with sMTC should not be considered a preneoplastic lesion as they are negative for the mutation of the main sMTC.</p>\",\"PeriodicalId\":11884,\"journal\":{\"name\":\"European Journal of Endocrinology\",\"volume\":\" \",\"pages\":\"737-743\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ejendo/lvaf109\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejendo/lvaf109","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Genetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia.
Objective: Sporadic medullary thyroid cancer (sMTC) mostly presents as a single lesion, but additional tumor foci may be present. The present study aimed to analyze the mutation profile of different tumor foci of multifocal sMTC to verify whether they represent an intra-organ metastatic dissemination or if they are independent tumors. Moreover, the genetics of C-cell hyperplasia (CCH) associated with sMTC was studied to verify whether CCH could be considered preneoplastic or reactive lesions.
Methods: Thirty-eight multifocal sMTCs and 15 sMTCs with associated CCH were included: A total of 106 tumor foci and 25 different CCH areas were studied. The mutational status was analyzed by Next-Generation Sequencing and/or droplet-digital PCR.
Results: Thirty-one/38 (81.6%) sMTCs had a somatic mutation in the main tumor, while 7/38 (18.4%) cases were negative. Thirty/31 (96.8%) mutated sMTCs had a single mutation, while 3 different mutations were detected in 1 case (3.2%). Twenty-eight/31 (90%) mutated sMTCs showed the same mutation profile in the main tumors and in all secondary foci, while 3 cases were discordant. Eleven/15 (73.4%) sMTC with CCH showed a somatic mutation in the main tumor, while 4 (26.6%) were negative. Only 1/11 (9%) mutated cases showed the same mutation in the main tumor and in the CCH.
Conclusions: Our data demonstrate that multiple foci of sMTC share the same driver mutation as the main tumor and support the hypothesis that they are intrathyroidal metastases. Most of the CCH associated with sMTC should not be considered a preneoplastic lesion as they are negative for the mutation of the main sMTC.
期刊介绍:
European Journal of Endocrinology is the official journal of the European Society of Endocrinology. Its predecessor journal is Acta Endocrinologica.
The journal publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines, position statements and debates. Case reports will only be considered if they represent exceptional insights or advances in clinical endocrinology.
Topics covered include, but are not limited to, Adrenal and Steroid, Bone and Mineral Metabolism, Hormones and Cancer, Pituitary and Hypothalamus, Thyroid and Reproduction. In the field of Diabetes, Obesity and Metabolism we welcome manuscripts addressing endocrine mechanisms of disease and its complications, management of obesity/diabetes in the context of other endocrine conditions, or aspects of complex disease management. Reports may encompass natural history studies, mechanistic studies, or clinical trials.
Equal consideration is given to all manuscripts in English from any country.